Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Change in Intangibles: 2016-2021

Historic Change in Intangibles for Altimmune (ALT) over the last 5 years, with Dec 2021 value amounting to $5,000.

  • Altimmune's Change in Intangibles fell 87.36% to $5,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $195,000, marking a year-over-year increase of 40.83%. This contributed to the annual value of $195,000 for FY2021, which is 40.83% up from last year.
  • As of Q4 2021, Altimmune's Change in Intangibles stood at $5,000, which was down 88.89% from $45,000 recorded in Q3 2021.
  • Over the past 5 years, Altimmune's Change in Intangibles peaked at $83,000 during Q2 2021, and registered a low of $1,082 during Q4 2018.
  • Moreover, its 3-year median value for Change in Intangibles was $19,474 (2020), whereas its average is $30,103.
  • As far as peak fluctuations go, Altimmune's Change in Intangibles skyrocketed by 1,565.45% in 2020, and later slumped by 87.36% in 2021.
  • Altimmune's Change in Intangibles (Quarterly) stood at $6,252 in 2017, then plummeted by 82.69% to $1,082 in 2018, then spiked by 119.59% to $2,376 in 2019, then surged by 1,565.45% to $39,571 in 2020, then plummeted by 87.36% to $5,000 in 2021.
  • Its Change in Intangibles stands at $5,000 for Q4 2021, versus $45,000 for Q3 2021 and $83,000 for Q2 2021.